Patients can safely skip pre-surgery stress tests and beta blockers

Dec 02, 2009

Physicians should "throttle back" from routinely ordering stress tests and prescribing beta blockers to patients before non-cardiac surgeries, according to a report by the University of Michigan released online this week.

Studies suggest such pre-operative tests and medications do not save lives and patients can skip them without suffering complications later, the U-M physicians write in a special report released ahead of print in .

The article by U-M physicians appears as the American College of Cardiology and American Heart Association release new guidelines showing pre-operative medications should be reserved for only high risk patients undergoing complicated surgeries.

But U-M physicians go a step further by critically evaluating other costly pre-operative practices -- stress testing and coronary revascularizations such as stenting and bypass surgery for patients with stable heart disease.

These patients do not benefit from as studies show that it may trigger as many events as it prevents.

"Physicians may struggle with implementing these evidence-based guidelines for a variety of reasons, including legal concerns regarding pre-operative , pressure from surgical colleagues and reliance on testing and procedures for income," says senior author Kim Eagle, M.D., director of the U-M Cardiovascular Center and the Albion Walter Hewlett Professor of Internal Medicine.

"It's imperative that any form of health care reform provide incentives to follow these guidelines," Eagle says. "It is the quality of care, not the quantity of tests, that matters most."

Eagle and his U-M colleagues describe screening patients with stable cardiac disease before non-cardiac surgeries such as and gallbladder surgery as a failed strategy.

Stress tests do not reliably predict potentially fatal issues such as coronary artery clots and spasms, and can harm patients whose heart disease is stable if dosages are not carefully monitored over months. Most patients are given the new medications in the days and weeks before surgery and before they can have a significant impact on relieving stress on the heart.

"Traditionally we've thought of stress tests as the best way to figure out whether a patient is ready for surgery," says Vineet I. Chopra, M.D., a hospitalist at UMHS and clinical assistant professor of internal medicine at the U-M Medical School.

"It appears that many noninvasive stress tests are not only unnecessary, but potentially misleading," Chopra says. "Occasionally such testing may lead to unnecessary invasive testing which has its own set of risks, or unnecessary medical treatment which also has some risks attached," he says.

The new ACC/AHA guidelines on beta blockers advise doctors to identify the correct patients for medical therapy, rather than use a one-size fits all approach. Broad recommendations to treat all diabetics and those with high blood pressure with the medications before surgery are no longer the case, Chopra says.

Source: University of Michigan Health System (news : web)

Explore further: Engineering new bone growth

add to favorites email to friend print save as pdf

Related Stories

Bypass not to blame for heart patients' mental decline

May 19, 2008

Heart patients often experience lasting problems with memory, language, and other cognitive skills after bypass surgery. However, these problems aren’t caused by the surgery itself or the pump used to replace heart function ...

Recommended for you

Better living through mitochondrial derived vesicles

19 hours ago

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

20 hours ago

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

Engineering new bone growth

23 hours ago

MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated scaffold ...

User comments : 0